Skip to main content
Clinical Trials/NCT02378285
NCT02378285CompletedNot Applicable

Treatment of Epicondylitis by Ultrasound-guided Local Injections of Autologous Conditioned Plasma (ACP®): a Double-blind Placebo-controlled Randomized Clinical Trial With One-year Follow-up

Arthrex SAS2 sites in 1 country50 target enrollmentStarted: October 1, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
50
Locations
2
Primary Endpoint
Global pain score

Study Overview

Brief Summary

The purpose of this study is to assess efficacy of two intra-tendinous injections of platelet-rich plasma (PRP) on epicondylitis of recent evolution (≤ 3 months) compared compared to two intra-tendinous injections of saline solution (placebo).

Detailed Description

This was a prospective double-blind placebo-controlled randomized trial. Two ultrasound-guided injections of either PRP (ACP®, Arthrex) or saline solution were performed at 4 weeks interval.

Exclusion criterion was previous corticosteroid infiltration. All infiltrations were performed by Dr Bernard Montalvan. The selection of patients and the evaluation were conducted by Dr Patrick Le Goux who did not know which treatment had been allocated to which patient.

In the facility, no one apart from the investigators had access to full patient data.

An independent company represented by Mrs Amandine Ramseyer was hired to design, follow and carry the statistical analysis of the study. The data she got from the investigators were anonymous.

Patients were monitored by an independent evaluator blinded to treatment at baseline and 1, 3, 6 and 12 months follow-up.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
35 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients suffering from tennis elbow for less than three months
  • Patients having never received former medical or orthopedic treatment for tennis elbow

Exclusion Criteria

  • Patients having received any treatment for this specific pathology
  • Evidence of ongoing tumoral affection (controlled by MRI)
  • Tennis elbow history
  • Elbow fracture history
  • Associated elbow pathology
  • Inflammatory rheumatic disorders
  • Bleeding disorders
  • Ongoing anticoagulation therapy
  • Allergy to local anesthetic
  • Ongoing or previous cancer affection
  • Pregnancy

Outcomes

Primary Outcomes

Global pain score

Time Frame: 1 year

Secondary Outcomes

  • Roles and Maudsley score(1 year)
  • Pain on ECRB* contraction(1 year)
  • Pain on EDC** contraction(1 year)

Investigators

Sponsor
Arthrex SAS
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials